Technical Analysis for HQL - H&Q Life Sciences Investors

Grade Last Price % Change Price Change
grade B 17.65 0.86% 0.15
HQL closed up 0.86 percent on Friday, January 18, 2019, on 59 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical HQL trend table...

Date Alert Name Type % Chg
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Wide Bands Range Expansion 0.86%
Jan 17 Overbought Stochastic Strength 0.86%
Jan 16 Overbought Stochastic Strength 1.67%
Jan 15 180 Bullish Setup Bullish Swing Setup 1.44%
Jan 15 Overbought Stochastic Strength 1.44%
Jan 14 Overbought Stochastic Strength 2.86%
Jan 11 Overbought Stochastic Strength 1.09%
Jan 11 Up 3 Days in a Row Strength 1.09%

Older signals for HQL ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
H&Q Life Sciences Investors is a close ended equity mutual fund launched and managed by Hambrecht & Quist Capital Management, LLC. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating in the health technology and life sciences industries. It also invests in stocks of early and later stage financings of privately held companies, private placements by public companies. The fund invests in growth stocks of companies operating across all market capitalizations. It employs fundamental analysis with a focus on factors such as potential for above-average, long-term growth in revenues and earnings securities strong market position for their services or products, experienced business management, and, recognized technological expertise. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. H&Q Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Is HQL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.59
52 Week Low 13.95
Average Volume 123,186
200-Day Moving Average 18.6561
50-Day Moving Average 16.8368
20-Day Moving Average 16.1625
10-Day Moving Average 17.308
Average True Range 0.425
ADX 26.64
+DI 29.3959
-DI 18.8245
Chandelier Exit (Long, 3 ATRs ) 16.405
Chandelier Exit (Short, 3 ATRs ) 15.225
Upper Bollinger Band 18.6337
Lower Bollinger Band 13.6913
Percent B (%b) 0.8
BandWidth 30.579428
MACD Line 0.3112
MACD Signal Line 0.0819
MACD Histogram 0.2293
Fundamentals Value
Market Cap 373.65 Million
Num Shares 21.2 Million
EPS 3.98
Price-to-Earnings (P/E) Ratio 4.43
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.07
Resistance 3 (R3) 18.03 17.86 18.00
Resistance 2 (R2) 17.86 17.75 17.88 17.98
Resistance 1 (R1) 17.75 17.68 17.81 17.79 17.95
Pivot Point 17.58 17.58 17.60 17.60 17.58
Support 1 (S1) 17.47 17.47 17.53 17.51 17.35
Support 2 (S2) 17.30 17.40 17.32 17.32
Support 3 (S3) 17.19 17.30 17.30
Support 4 (S4) 17.23